Litcius/Paper detail

SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice

Yu-ran Ren, Yangliang Ye, Ying Feng, Tifei Xu, Yu Shen, Jia Liu, Suling Huang, Jianhua Shen, Ying Leng

2021Acta Pharmacologica Sinica15 citationsDOIOpen Access PDF

Topics & Concepts

GluconeogenesisPhosphoenolpyruvate carboxykinaseAcetylationSIRT2EndocrinologyInternal medicineChemistryNAD+ kinaseAcetyltransferaseGlycolysisBiochemistryGlucose homeostasisHistone acetyltransferaseMetabolismBiologyDiabetes mellitusEnzymeInsulin resistanceSirtuinMedicineGeneSirtuins and Resveratrol in MedicineMetabolism, Diabetes, and CancerBiochemical Acid Research Studies
SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice | Litcius